What is ProSurg?
ProSurg Inc. is a privately held medical device firm headquartered in Silicon Valley, California. The company is dedicated to the development and commercialization of innovative medical products targeting minimally invasive procedures within urology and gynecology. Their product portfolio includes proprietary offerings such as the NeoScope and Salinetrode Flex, designed for compatibility with standard endoscopic instruments and RF generators. ProSurg's focus on advanced solutions aims to enhance healthcare professional capabilities in minimally invasive surgery.
How much funding has ProSurg raised?
ProSurg has raised a total of $106K across 1 funding round:
Debt
$106K
Debt (2021): $106K with participation from PPP
Key Investors in ProSurg
PPP
Public-Private Partnership
What's next for ProSurg?
With substantial late-stage funding, ProSurg is strategically positioned for accelerated growth and market penetration. The recent major strategic investment signals strong investor confidence in the company's technology and business model. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand commercialization efforts globally. ProSurg's continued innovation in urological and gynecological devices suggests a future focused on solidifying its leadership in the minimally invasive surgery sector.
See full ProSurg company page
